On September 7, 2021 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, will participate in two upcoming virtual investor conferences (Press release, Leap Therapeutics, SEP 7, 2021, View Source [SID1234587354]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13. 2021
Time: 7:00 a.m. ET
Baird 2021 Global Healthcare Conference
Date: Wednesday, September 15, 2021
Time: 3:10 p.m. ET
A live webcast of the Baird fireside chat and a replay of the pre-recorded H.C. Wainwright presentation may be accessed on the Investors page of the company’s website at View Source, where a replay of the events will also be available for a limited time.